Slow-Coagulation Transscleral Cyclophotocoagulation Laser Treatment for Medically Uncontrolled Secondary Aphakic Adult Glaucoma.
Journal
Journal of glaucoma
ISSN: 1536-481X
Titre abrégé: J Glaucoma
Pays: United States
ID NLM: 9300903
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
received:
29
01
2023
accepted:
25
04
2023
medline:
16
8
2023
pubmed:
12
5
2023
entrez:
12
5
2023
Statut:
ppublish
Résumé
Slow-coagulation CW-TSCPC is an efficacious, relatively safe, and non-incisional laser treatment option as an initial surgical glaucoma management choice, in secondary aphakic adult glaucoma that is medically uncontrolled. This study evaluates the outcomes of slow-coagulation continuous wave transscleral cyclophotocoagulation (CW-TSCPC) laser for treating secondary aphakic adult glaucoma after complicated cataract surgery as a primary surgical intervention. A retrospective chart review of adult aphakic eyes with medically uncontrolled glaucoma underwent slow-coagulation CW-TSCPC as a primary surgical glaucoma intervention was performed. Surgical success was the primary outcome measure. Success was defined as postoperative intraocular pressure (IOP) between 6 and 21 mm Hg with ≥20% reduction compared with baseline and no need for further glaucoma surgeries or development of vision-threatening complications. The secondary outcomes included changes in IOP, glaucoma medication numbers, visual acuity, and postoperative complications during the first year after laser treatment after laser treatment. This study included 41 eyes of 41 patients. The mean age of study participants was 66.7±13.1 years, with a mean follow-up duration of 19±3.5 months. At one year, the success rate was 63.4%. A statistically significant reduction of the IOP was observed, with the mean IOP decreasing from 29.6±5.8 mm Hg with a mean of 3.9±1.0 medications at baseline to a mean of 19.0±6.4 mm Hg with a mean of 2.5±1.2 medications at 12 months ( P <0.001). Four eyes received CW-TSCPC retreatment, and 2 eyes required incisional glaucoma surgeries. Reported postoperative complications included: visual acuity decline ≥2 lines in 7 eyes, iritis in 6 eyes, hyphema in 5 eyes, cystoid macular edema in 2 eyes, and transient hypotony in 1 eye. Slow-coagulation CW-TSCPC is an efficacious, relatively safe, and non-incisional laser treatment option as an initial surgical glaucoma management choice, in secondary aphakic adult glaucoma that is medically uncontrolled.
Identifiants
pubmed: 37172013
doi: 10.1097/IJG.0000000000002237
pii: 00061198-990000000-00217
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
695-700Subventions
Organisme : NEI NIH HHS
ID : P30 EY014801
Pays : United States
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure: The authors declare no conflict of interest.
Références
Jonas JB, Aung T, Bourne RR, et al. Glaucoma. Lancet. 2017;390:2183–2193.
Zhang N, Wang J, Li Y, et al. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021;11:13762.
Lundström M, Brege KG, Florén I, et al. Postoperative aphakia in modern cataract surgery: part 1: analysis of incidence and risks based on 5-year data from the Swedish National Cataract Register. J Cataract Refract Surg. 2004;30:2105–2110.
Nirmalan PK, Thulasiraj RD, Maneksha V, et al. A population based eye survey of older adults in Tirunelveli district of south India: blindness, cataract surgery, and visual outcomes. Br J Ophthalmol. 2002;86:505–512.
Arvind H, George R, Raju P, et al. Glaucoma in aphakia and pseudophakia in the Chennai Glaucoma Study. Br J Ophthalmol. 2005;89:699–703.
Ekşioğlu Ü, Yakin M, Balta Ö, et al. The profile and management of glaucoma in adult aphakic patients following complicated cataract surgery. Turk J Ophthalmol. 2018;48:19–22.
Agarwal H, Sood N, Dayal Y. Aphakic glaucoma. Indian J Ophthalmol. 1981;29:221–225.
Freedman SF, Beck AD, Nizam A, et al. Glaucoma-related adverse events at 10 years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021;139:165–173.
Chandler PA. Glaucoma from pupillary block in aphakia. Trans Am Ophthalmol Soc. 1961;59:96–105.
Sharma SL, Singh T. Clinical evaluation of trabeculectomy operation in aphakic glaucoma. Indian J Ophthalmol. 1981;29:227–228.
Massy J, Gruber D, Muraine M, et al. [Non-penetrating deep sclerectomy in the surgical treatment of chronic open-angle glaucoma. Mid-term results] J Fr Ophtalmol. 1999;22:292–298.
Jamerson EC, Solyman O, Yacoub MS, et al. Angle surgery in pediatric glaucoma following cataract surgery. Vision (Basel). 2021;5:9.
Tomey KF, Traverso CE. The glaucomas in aphakia and pseudophakia. Surv Ophthalmol. 1991;36:79–112.
Gross RL, Feldman RM, Spaeth GL, et al. Surgical therapy of chronic glaucoma in aphakia and pseudophakia. Ophthalmology. 1988;95:1195–1201.
Chen MF, Kim CH, Coleman AL. Cyclodestructive procedures for refractory glaucoma. Cochrane Database Syst Rev. 2019;3:Cd012223.
Anand N, Klug E, Nirappel A, et al. A review of cyclodestructive procedures for the treatment of glaucoma. Semin Ophthalmol. 2020;35:261–275.
Moussa K, Feinstein M, Pekmezci M, et al. Histologic changes following continuous wave and micropulse transscleral cyclophotocoagulation: a randomized comparative study. Transl Vis Sci Technol. 2020;9:22.
Khodeiry MM, Liu X, Lee RK. Clinical outcomes of slow-coagulation continuous-wave transscleral cyclophotocoagulation laser for treatment of glaucoma. Curr Opin Ophthalmol. 2022;33:237–42.
Duerr ER, Sayed MS, Moster S, et al. Transscleral diode laser cyclophotocoagulation: A comparison of slow coagulation and standard coagulation techniques. Ophthalmol Glaucoma. 2018;1:115–122.
Fong YYY, Wong BKT, Li FCH, et al. A retrospective study of transcleral cyclophotocoagulation using the slow coagulation technique for the treatment of refractory glaucoma. Semin Ophthalmol. 2019;34:398–402.
Yelenskiy A, Gillette TB, Arosemena A, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma. 2018;27:920–925.
Abbas A, Agrawal P, King AJ. Exploring literature-based definitions of hypotony following glaucoma filtration surgery and the impact on clinical outcomes. Acta Ophthalmol (Copenh). 2018;96:e285–e289.
Khodeiry MM, Sheheitli H, Sayed MS, et al. Treatment outcomes of slow coagulation transscleral cyclophotocoagulation in pseudophakic patients with medically uncontrolled glaucoma. Am J Ophthalmol. 2021;229:90–99.
Khodeiry MM, Lauter AJ, Sayed MS, et al. Primary slow-coagulation transscleral cyclophotocoagulation laser treatment for medically recalcitrant neovascular glaucoma. Br J Ophthalmol. 2023;107:671–676.
Sheheitli H, Persad PJ, Feuer WJ, et al. Treatment outcomes of primary transscleral cyclophotocoagulation. Ophthalmol Glaucoma. 2021;4:472–481.
Egbert PR, Fiadoyor S, Budenz DL, et al. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol. 2001;119:345–350.
Gorsler I, Thieme H, Meltendorf C. Cyclophotocoagulation and cyclocryocoagulation as primary surgical procedures for open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2015;253:2273–2277.
Grueb M, Rohrbach JM, Bartz-Schmidt KU, et al. Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliatve glaucoma. Long-term clinical outcomes. Graefes Arch Clin Exp Ophthalmol. 2006;244:1293–1299.
Souissi S, Le Mer Y, Metge F, et al. An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma. Acta Ophthalmol (Copenh). 2021;99:e621–e653.